Danaher Corporation (DHR)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 22 | 29 | 27 | 24 | 24 | 25 | 25 | 26 |
| Operating profit | $bn | 5 | 5 | ||||||
| Net profit | $bn | 4 | 6 | 7 | 5 | 4 | 4 | 4 | 6 |
| EPS reported | $ | 5.04 | 5.63 | ||||||
| Operating cashflow per share | $ | 9.07 | 9.41 | ||||||
| Capex per share | $ | 1.63 | 1.66 | ||||||
| FCF per share | $ | 7.44 | 7.75 | ||||||
| Free cash flow | $bn | 5 | 5 | ||||||
| Net debt | $bn | 14 | 22 | ||||||
| Book value equity | $bn | 53 | 53 | ||||||
| Book value per share | $ | 73.89 | 74.31 | ||||||
| Number of shares | m | 711 | 707.6 | ||||||
| DPS (TTM paid) | $ | 1.28 | 1.52 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 45.42 | 39.87 | ||||||
| P/B LTM | x | 3.08 | 3.08 | ||||||
| P/S LTM | x | 6.59 | 6.45 | ||||||
| P/FCF LTM | x | 30.78 | 29.62 | ||||||
| EV/EBITDA LTM | x | 25.30 | 24.57 | ||||||
| EV/Sales LTM | x | 7.15 | 6.70 | ||||||
| Earnings Yield LTM | % | +2.20% | +2.51% | ||||||
| FCF Yield | % | +3.25% | +3.38% | ||||||
| Quality | |||||||||
| ROE | % | +6.88% | +7.66% | ||||||
| ROIC | % | +5.72% | +5.03% | ||||||
| Operating margin | % | +20.91% | +20.42% | ||||||
| Gross margin | % | +60.93% | +58.51% | ||||||
| FCF/Sales | % | +21.41% | +21.77% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -4.73% | +6.43% | ||||||
| Sales Growth YoY | % | +2.90% | +5.16% | ||||||
| Net Income Growth YoY | % | -7.31% | +2.69% | ||||||
| FCF Growth | % | -0.68% | +3.21% | ||||||
| Operating Profit Growth | % | -0.91% | -1.10% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.54% | +0.69% | ||||||
| Dividend Growth | % | +18.52% | +40.74% | ||||||
| Payout Ratio | % | +24.50% | +24.09% | ||||||
| FCF/Debt | x | 0.29 | 0.21 | ||||||
| Net Debt/EBITDA | x | 1.99 | 3.11 | ||||||
| EBIT/Net interest | x | 19.38 | 65.73 | ||||||
| Net debt/market cap | % | +11.38% | +18.19% | ||||||
| Net debt/Equity | x | 0.26 | 0.42 | ||||||
| Gross debt/equity | x | 0.35 | 0.51 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free